Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.
2.

Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM.

Anfossi G, Mularoni EM, Burzacca S, Ponziani MC, Massucco P, Mattiello L, Cavalot F, Trovati M.

Diabetes Care. 1998 Jan;21(1):121-6.

PMID:
9538982
3.

Antiplatelet effects of policosanol (20 and 40 mg/day) in healthy volunteers and dyslipidaemic patients.

Arruzazabala ML, Molina V, Mas R, Fernández L, Carbajal D, Valdés S, Castaño G.

Clin Exp Pharmacol Physiol. 2002 Oct;29(10):891-7.

PMID:
12207568
4.
5.

[Inhibitory effect of isosorbide dinitrate on whole blood aggregation].

Yoshimoto H, Suehiro A, Higasa S, Seto T, Oku KI, Kakishita E.

J Cardiol. 1997 Apr;29(4):195-201. Japanese.

PMID:
9127835
6.

Comparison of the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers.

Niemi TT, Taxell C, Rosenberg PH.

Acta Anaesthesiol Scand. 1997 Nov;41(10):1353-8.

PMID:
9422305
7.

In vitro and in vivo studies of the effect of aztreonam on platelet function and coagulation in normal volunteers.

Tartaglione TA, Duma RJ, Qureshi GD.

Antimicrob Agents Chemother. 1986 Jul;30(1):73-7.

8.

Inhibitory effect of aqueous extracts of some herbs on human platelet aggregation in vitro.

Pierre S, Crosbie L, Duttaroy AK.

Platelets. 2005 Dec;16(8):469-73.

PMID:
16287614
9.

alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism.

Freedman JE, Farhat JH, Loscalzo J, Keaney JF Jr.

Circulation. 1996 Nov 15;94(10):2434-40.

10.

Cicaprost, an orally active prostacyclin analogue: its effects on platelet aggregation and skin blood flow in normal volunteers.

Belch JJ, McLaren M, Lau CS, Mackay IR, Bancroft A, McEwen J, Thompson JM.

Br J Clin Pharmacol. 1993 Jun;35(6):643-7.

11.

Inhibition of streptokinase-induced, antibody-mediated platelet aggregation with tirofiban after exposure to streptokinase or streptococcal infection.

Courval M, Palisaitis DA, Diodati JG, Lesperance B, Pharand C.

Pharmacotherapy. 2004 May;24(5):558-63.

PMID:
15162889
12.

Inhibition of platelet aggregation by aspirin progressively decreases in long-term treated patients.

Pulcinelli FM, Pignatelli P, Celestini A, Riondino S, Gazzaniga PP, Violi F.

J Am Coll Cardiol. 2004 Mar 17;43(6):979-84.

13.

Effects of the new glycopeptide antibiotic teicoplanin on platelet function and blood coagulation.

Agnelli G, Longetti M, Guerciolini R, Menichetti F, Grasselli S, Boldrini F, Bucaneve G, Nenci GG, Del Favero A.

Antimicrob Agents Chemother. 1987 Oct;31(10):1609-12.

14.

Inhibitory effects of urinary metabolites on platelet aggregation after orally administering Shimotsu-To, a traditional Chinese medicine, to rats.

Yasuda T, Takasawa A, Nakazawa T, Ueda J, Ohsawa K.

J Pharm Pharmacol. 2003 Feb;55(2):239-44.

PMID:
12631416
15.

Platelet inhibitory activity and pharmacokinetics of prasugrel (CS-747) a novel thienopyridine P2Y12 inhibitor: a single ascending dose study in healthy humans.

Asai F, Jakubowski JA, Naganuma H, Brandt JT, Matsushima N, Hirota T, Freestone S, Winters KJ.

Platelets. 2006 Jun;17(4):209-17.

PMID:
16769598
16.

Bioequivalence of two preparations of ticlopidine evaluated using a pharmacodynamic end point.

Splawinski J, Kuzniar J, Kurianowicz R, Wanczura P.

Int J Clin Pharmacol Ther. 2005 Sep;43(9):452-6.

PMID:
16163899
17.

A 4-trifluoromethyl derivative of salicylate, triflusal, stimulates nitric oxide production by human neutrophils: role in platelet function.

De Miguel LS, Jiménez A, Montón M, Farré J, Del Mar Arriero M, Rodríguez-Feo JA, García-Cañete J, Rico L, Gómez J, Núñez A, Casado S, Farré AL.

Eur J Clin Invest. 2000 Sep;30(9):811-7.

PMID:
10998082
18.

Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D.

Sugidachi A, Ogawa T, Asai F, Saito S, Ozaki H, Fusetani N, Karaki H, Koike H.

Thromb Haemost. 1998 Mar;79(3):614-9.

PMID:
9531051
19.

Inhibitory effect of the Korean herbal medicine, Dae-Jo-Whan, on platelet-activating factor-induced platelet aggregation.

Chang GT, Kang SK, Kim JH, Chung KH, Chang YC, Kim CH.

J Ethnopharmacol. 2005 Dec 1;102(3):430-9. Epub 2005 Aug 26.

PMID:
16125889
20.

Suppressive effect of captopril on platelet aggregation in essential hypertension.

Someya N, Morotomi Y, Kodama K, Kida O, Higa T, Kondo K, Tanaka K.

J Cardiovasc Pharmacol. 1984 Sep-Oct;6(5):840-3.

PMID:
6209489

Supplemental Content

Support Center